Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pablo Okhuysen, MD
M.D. Anderson Cancer Center
Principal Investigator - Pravin Chaturvedi, PhD
Napo Pharmaceuticals
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Buenos Aires British Hospital
Buenos Aires, Argentina
- Fleischer Medical Center
Buenos Aires, Argentina
- Medical Center Austral
Buenos Aires, Argentina
- Cordoba Oncology Institute (ionc)
Córdoba, Argentina
- Center of Nuclear and Molecular Medicine of Entre Rios (cemener)
Paraná, Argentina
- Cedit Diagnostic and Treatment Center
Salta, Argentina
- 9 of July Sanatorium
San Miguel de Tucumán, Argentina
- Isis Specialized Clinic
Santa Fe, Argentina
- Archangel St. Michael Multiprofile Clinical Hospital Ltd
Tbilisi, Georgia
- Jsc K. Eristavi National Center of Experimental and Clinical Surgery
Tbilisi, Georgia
- Llc "todua Clinic"
Tbilisi, Georgia
- Ltd Caucasus Medical Centre
Tbilisi, Georgia
- Malkhaz Katsiashvili Multiprofile Emergency Medicine Center Llc
Tbilisi, Georgia
- Clinical Hospital Center Bezanijska Kosa
Belgrade, Serbia
- National Cancer Research Center
Belgrade, Serbia
- Institute of Pulmonary Diseases of Vojvodina
Kamenitz, Serbia
- Oncology Institute of Vojvodina (iov)
Kamenitz, Serbia
- University Clinical Center Kragujevac
Kragujevac, Serbia
- University Clinical Center Nis
Niš, Serbia
- Changhua Christian Hospital
Changhua, Taiwan
- Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
- China Medical University Hospital
Taichung, Taiwan
- Chi Mei Medical Center - Liouying Branch
Tainan, Taiwan
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hospital
Taipei, Taiwan
- Arizona Oncology Associates Pc - Hal
Prescott, Arizona, United States
- Pacific Cancer Medical Center Inc
Anaheim, California, United States
- the Oncology Institute of Hope and Innovation
Corona, California, United States
- the Oncology Institute of Hope and Innovation
Glendale, California, United States
- Pih Health Whittier Hospital
Whittier, California, United States
- Scl Health Research Institute
Lafayette, Colorado, United States
- Genesiscare Usa
Aventura, Florida, United States
- Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida, United States
- Brcr Global
Plantation, Florida, United States
- Advanced Research Institute
St. Petersburg, Florida, United States
- American Oncology Partners of Maryland
Bethesda, Maryland, United States
- Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- North Shore Hematology Oncology Associates Dba New York Cancer and Blood Specialists
Port Jefferson Station, New York, United States
- Jacobi Medical Center
The Bronx, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Oct 2020
- Primary completion
- 7 Aug 2023
- Completion
- 30 Oct 2023
- Last update posted
- 26 Jul 2024
- Registered enrollment
- 287
- Registry id
- NCT04538625
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.